T cell reactivity in response to S peptide pools of HCoVs were variable with slightly lower frequencies of CD4+CD154+CD137+ activated T cells reactive to C-terminal S of HCoV-229E and -OC43 in post COVID-19 individuals compared to HC. The gene discussed is CD40LG; the disease is COVID-19.